Savavet Visiocare Cyclosporine OPHTHALMIC OINTMENT for Dogs

Visiocare ophthalmic ointment is indicated for management of chronic keratoconjunctivitis sicca (KCS) and chronic superficial keratitis (CKS) in dogs.

Time tested for nearly two decades worldwide for the treatment of KCS

Unique mechanism of immune suppression 

The only veterinary ophthalmic product for both symptoms and underlining cause

Uses  microemulsification technology which increase bioavailability, reduce side effects

COMPOSITION:

Cyclosporine IP               2mg/gm

DOSAGE AND ADMINISTRATION:

Remove debris with suitable non-irritating solutions. Apply a ¼ inch strip of ointment to the affected eye(s) every 12 hours. The ointment may be placed directly on the cornea or into the conjunctival sac.

It is recommended that dogs exhibiting chronic recurring conjunctivitis be tested for adequate tear production to determine if they are suffering from early stages of chronic KCS.

For best results in treating KCS, cyclosporin ophthalmic ointment should be administered early in the course of the disease before irreversible damage to the lacrimal tissue, or dense corneal scarring or pigmentation occurs.

Dogs afflicted with KCS or CKS will most likely require lifelong consistent therapy. For CSK, because environmental factors such as ultraviolet (UV) radiation are implicated in the pathogenesis, clinical signs may subside in the winter months when light intensity is reduced or if the dog is moved to a lower altitude, or indoors, and thus exposed to less UV radiation.

In cases refractory to cyclosporin, the diagnosis should be re-evaluated and a different course of therapy considered. Periodic reassessment of the need for Visiocare ophthalmic ointment therapy is recommended.